Compile Data Set for Download or QSAR
Report error Found 74 Enz. Inhib. hit(s) with all data for entry = 50012418
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472930((R)-4-propyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataEC50:  0.0631nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459712(CHEMBL4218374 | US10836764, Compound 173)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM473021((R)-4-benzyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557509(CHEMBL4791279)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557510(CHEMBL4750329)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557505(CHEMBL4776557)
Affinity DataEC50:  0.200nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557506(CHEMBL4757718)
Affinity DataEC50:  3.20nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459717(CHEMBL4209572)
Affinity DataEC50:  100nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557507(CHEMBL4750216)
Affinity DataEC50:  5nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472949((R)-4-methyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataEC50:  2nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557508(CHEMBL4778104)
Affinity DataEC50:  6.30nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557506(CHEMBL4757718)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459713(CHEMBL4213447 | US10836764, Compound 176)
Affinity DataEC50:  0.100nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459718(CHEMBL4213379 | US10836764, Compound 106)
Affinity DataEC50:  0.126nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472931((R)-4-isobutyl-6,6a,7,8,9,10-hexahydro-5H- pyrazin...)
Affinity DataEC50:  0.398nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459708(CHEMBL4206126 | US10836764, Compound 152)
Affinity DataEC50:  1.30nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataEC50:  5nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459711(CHEMBL4217846)
Affinity DataEC50:  316nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459712(CHEMBL4218374 | US10836764, Compound 173)
Affinity DataEC50:  1.30nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM473021((R)-4-benzyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataEC50:  0.631nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557509(CHEMBL4791279)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557510(CHEMBL4750329)
Affinity DataEC50: <1.00E+3nMAssay Description:Agonist activity at 5-HT2CR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472954((R)-4-(methoxymethyl)-6,6a,7,8,9,10-hexahydro- 5H-...)
Affinity DataEC50:  794nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459711(CHEMBL4217846)
Affinity DataEC50:  794nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557505(CHEMBL4776557)
Affinity DataEC50:  158nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459717(CHEMBL4209572)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557507(CHEMBL4750216)
Affinity DataEC50:  1.26E+3nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557508(CHEMBL4778104)
Affinity DataEC50:  398nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459718(CHEMBL4213379 | US10836764, Compound 106)
Affinity DataEC50:  50nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459708(CHEMBL4206126 | US10836764, Compound 152)
Affinity DataEC50:  1.00E+3nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459711(CHEMBL4217846)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557509(CHEMBL4791279)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2A(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557510(CHEMBL4750329)
Affinity DataEC50: <1.00E+4nMAssay Description:Agonist activity at 5-HT2AR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557505(CHEMBL4776557)
Affinity DataEC50:  100nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557506(CHEMBL4757718)
Affinity DataEC50:  3.16E+3nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459717(CHEMBL4209572)
Affinity DataEC50:  63nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557507(CHEMBL4750216)
Affinity DataEC50:  50nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472949((R)-4-methyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataEC50:  40nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557508(CHEMBL4778104)
Affinity DataEC50:  16nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472930((R)-4-propyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataEC50:  200nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459713(CHEMBL4213447 | US10836764, Compound 176)
Affinity DataEC50:  158nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459718(CHEMBL4213379 | US10836764, Compound 106)
Affinity DataEC50:  794nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472931((R)-4-isobutyl-6,6a,7,8,9,10-hexahydro-5H- pyrazin...)
Affinity DataEC50:  316nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2B(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459708(CHEMBL4206126 | US10836764, Compound 152)
Affinity DataEC50:  1.26E+3nMAssay Description:Agonist activity at 5-HT2BR (unknown origin) transfected in human HEK293 cells by IP3 accumulation assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472930((R)-4-propyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataKi:  0.158nMAssay Description:Displacement of [125I]-DOI from recombinant human 5HT2CR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459718(CHEMBL4213379 | US10836764, Compound 106)
Affinity DataKi:  0.251nMAssay Description:Displacement of [125I]-DOI from recombinant human 5HT2CR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50557505(CHEMBL4776557)
Affinity DataKi:  0.316nMAssay Description:Displacement of [125I]-DOI from recombinant human 5HT2CR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50459713(CHEMBL4213447 | US10836764, Compound 176)
Affinity DataKi:  0.501nMAssay Description:Displacement of [125I]-DOI from recombinant human 5HT2CR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM473021((R)-4-benzyl-6,6a,7,8,9,10-hexahydro-5H- pyrazino[...)
Affinity DataKi:  0.501nMAssay Description:Displacement of [125I]-DOI from recombinant human 5HT2CR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Target5-hydroxytryptamine receptor 2C(Human)
Arena Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM472931((R)-4-isobutyl-6,6a,7,8,9,10-hexahydro-5H- pyrazin...)
Affinity DataKi:  0.631nMAssay Description:Displacement of [125I]-DOI from recombinant human 5HT2CR transfected in human HEK293 cells incubated for 45 mins by radioligand binding assayMore data for this Ligand-Target Pair
In Depth
Date in BDB:
3/26/2022
Entry Details Article
PubMed
Displayed 1 to 50 (of 74 total ) | Next | Last >>
Jump to: